{"id":40795,"date":"2026-06-24T08:20:39","date_gmt":"2026-06-24T07:20:39","guid":{"rendered":"https:\/\/www.argonandco.com\/?post_type=article&#038;p=40795"},"modified":"2026-06-24T08:20:39","modified_gmt":"2026-06-24T07:20:39","slug":"supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard","status":"publish","type":"article","link":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/","title":{"rendered":"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard"},"content":{"rendered":"<p><span class=\"intro\">Dans l\u2019article \u00ab La cha\u00eene d\u2019approvisionnement face \u00e0 la crise permanente \u00bb, paru dans le magazine\u00a0<a href=\"https:\/\/pharmaceutiques.com\/\">Pharmaceutiques<\/a>\u00a0et r\u00e9dig\u00e9 par le journaliste Fabien Nizon, Franck Kakal,\u00a0Partner\u00a0chez Argon &amp; Co et sp\u00e9cialiste de la\u00a0Supply Chain et de l\u2019industrie\u00a0pharmaceutique,\u00a0\u00e9claire un basculement de fond : dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement.\u00a0<\/span><\/p>\n<h2 aria-level=\"3\"><span data-contrast=\"none\">Observer le passage d\u2019une logique d\u2019efficience \u00e0 une logique de r\u00e9silience<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559685&quot;:2211,&quot;335559738&quot;:40,&quot;335559739&quot;:0,&quot;335559991&quot;:1077}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">Pendant longtemps, les cha\u00eenes d\u2019approvisionnement ont \u00e9t\u00e9 con\u00e7ues pour gagner en fluidit\u00e9, en co\u00fbt et en rapidit\u00e9. Ce mod\u00e8le reste performant en p\u00e9riode stable, mais il montre ses limites lorsque les tensions g\u00e9opolitiques, les ruptures de transport ou les d\u00e9pendances critiques se multiplient. Ce que souligne Franck Kakal est donc essentiel : la question n\u2019est plus seulement de savoir comment optimiser un r\u00e9seau logistique, mais comment lui permettre d\u2019absorber l\u2019impr\u00e9vu sans compromettre l\u2019acc\u00e8s aux produits de sant\u00e9.<\/span><span data-ccp-props=\"{&quot;335559685&quot;:0,&quot;335559739&quot;:60}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"3\"><span data-contrast=\"none\">Mesurer ce que la pharma a de sp\u00e9cifique<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559685&quot;:2211,&quot;335559738&quot;:40,&quot;335559739&quot;:0,&quot;335559991&quot;:1077}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">L\u2019int\u00e9r\u00eat de cette analyse tient aussi \u00e0 la singularit\u00e9 du secteur pharmaceutique. Une\u00a0Supply\u00a0Chain\u00a0pharma ne se r\u00e9organise pas comme n\u2019importe quelle autre cha\u00eene logistique. Les contraintes r\u00e9glementaires, la tra\u00e7abilit\u00e9, les exigences qualit\u00e9 et la sensibilit\u00e9 des produits rendent chaque ajustement plus complexe. C\u2019est ce qui explique pourquoi des leviers comme le double\u00a0sourcing, les routes alternatives ou la segmentation des flux ne rel\u00e8vent pas d\u2019une simple bonne pratique : ils engagent en r\u00e9alit\u00e9 une transformation plus profonde des arbitrages industriels.<\/span><span data-ccp-props=\"{&quot;335559685&quot;:0,&quot;335559739&quot;:60}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"3\"><span data-contrast=\"none\">Questionner ce que r\u00e9v\u00e8le la crise permanente<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559685&quot;:2211,&quot;335559738&quot;:40,&quot;335559739&quot;:0,&quot;335559991&quot;:1077}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">En creux, l\u2019intervention de Franck Kakal invite \u00e0 se poser des questions plus larges. \u00c0 partir de quel moment un mod\u00e8le tr\u00e8s optimis\u00e9 devient-il trop expos\u00e9 ? Comment distinguer une vuln\u00e9rabilit\u00e9 acceptable d\u2019une d\u00e9pendance strat\u00e9gique ? Et surtout, comment b\u00e2tir une organisation capable de rester conforme, robuste et r\u00e9active \u00e0 la fois ? C\u2019est pr\u00e9cis\u00e9ment dans cette zone de r\u00e9flexion, entre contraintes concr\u00e8tes et choix de long terme, que cet \u00e9clairage d\u2019Argon &amp; Co apporte une vraie mati\u00e8re \u00e0 approfondir.<\/span><span data-ccp-props=\"{&quot;335559685&quot;:0,&quot;335559739&quot;:60}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/45-EnCouvLogistique.pdf\">Lire l&rsquo;article<\/a><\/p>\n","protected":false},"featured_media":40796,"template":"","categories":[416],"class_list":["post-40795","article","type-article","status-publish","has-post-thumbnail","hentry","category-life-sciences"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co<\/title>\n<meta name=\"description\" content=\"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l&#039;\u00e9clairage de Franck Kakal.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co\" \/>\n<meta property=\"og:description\" content=\"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l&#039;\u00e9clairage de Franck Kakal.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/\" \/>\n<meta property=\"og:site_name\" content=\"Argon &amp; Co\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/iStock-2232494006.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1448\" \/>\n\t<meta property=\"og:image:height\" content=\"724\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/\",\"url\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/\",\"name\":\"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.argonandco.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/iStock-2232494006.jpg\",\"datePublished\":\"2026-06-24T07:20:39+00:00\",\"description\":\"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l'\u00e9clairage de Franck Kakal.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.argonandco.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/iStock-2232494006.jpg\",\"contentUrl\":\"https:\\\/\\\/www.argonandco.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/iStock-2232494006.jpg\",\"width\":1448,\"height\":724,\"caption\":\"Automated tablet filling machine with glass bottles on a production conveyor line. Pharmaceutical industry, automation, drug manufacturing technology, healthcare supply chain, laboratory research, packaging process, medicine innovation, pharmacology, 3D illustration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Articles\",\"item\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/news-insights\\\/articles\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/\",\"name\":\"Argon &amp; Co\",\"description\":\"We help clients achieve their strategic and operational objectives, working together to transform their businesses and generate real change.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.argonandco.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co","description":"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l'\u00e9clairage de Franck Kakal.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/","og_locale":"fr_FR","og_type":"article","og_title":"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co","og_description":"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l'\u00e9clairage de Franck Kakal.","og_url":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/","og_site_name":"Argon &amp; Co","og_image":[{"width":1448,"height":724,"url":"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/iStock-2232494006.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/","url":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/","name":"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard - Argon &amp; Co","isPartOf":{"@id":"https:\/\/www.argonandco.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/#primaryimage"},"image":{"@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/#primaryimage"},"thumbnailUrl":"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/iStock-2232494006.jpg","datePublished":"2026-06-24T07:20:39+00:00","description":"Dans la pharma, la crise n\u2019est plus une parenth\u00e8se, elle devient un cadre de fonctionnement : l'\u00e9clairage de Franck Kakal.","breadcrumb":{"@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/#primaryimage","url":"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/iStock-2232494006.jpg","contentUrl":"https:\/\/www.argonandco.com\/wp-content\/uploads\/2026\/06\/iStock-2232494006.jpg","width":1448,"height":724,"caption":"Automated tablet filling machine with glass bottles on a production conveyor line. Pharmaceutical industry, automation, drug manufacturing technology, healthcare supply chain, laboratory research, packaging process, medicine innovation, pharmacology, 3D illustration"},{"@type":"BreadcrumbList","@id":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/supply-chain-dans-lindustrie-pharmaceutique-penser-linstabilite-comme-un-nouveau-standard\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.argonandco.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Articles","item":"https:\/\/www.argonandco.com\/fr\/news-insights\/articles\/"},{"@type":"ListItem","position":3,"name":"Supply chain dans l\u2019industrie pharmaceutique : penser l\u2019instabilit\u00e9 comme un nouveau standard"}]},{"@type":"WebSite","@id":"https:\/\/www.argonandco.com\/fr\/#website","url":"https:\/\/www.argonandco.com\/fr\/","name":"Argon &amp; Co","description":"We help clients achieve their strategic and operational objectives, working together to transform their businesses and generate real change.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.argonandco.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/article\/40795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/types\/article"}],"version-history":[{"count":2,"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/article\/40795\/revisions"}],"predecessor-version":[{"id":40805,"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/article\/40795\/revisions\/40805"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/media\/40796"}],"wp:attachment":[{"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/media?parent=40795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.argonandco.com\/fr\/wp-json\/wp\/v2\/categories?post=40795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}